Beam Therapeutics BEAM Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's operating lease liabilities?
- Beam Therapeutics (BEAM) reported operating lease liabilities of $135.85M in Q1 2026.
- How has Beam Therapeutics's operating lease liabilities changed year-over-year?
- Beam Therapeutics's operating lease liabilities decreased by 6.3% year-over-year, from $144.92M to $135.85M.
- What is the long-term trend for Beam Therapeutics's operating lease liabilities?
- Over 5 years (2020 to 2025), Beam Therapeutics's operating lease liabilities has grown at a 7.8% compound annual growth rate (CAGR), from $96.01M to $139.76M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.